Replies to post #727903 on NorthWest Biotherapeutics Inc (NWBO)

[flipper44]

Another monoclonal antibody company. Its primary product is for a blood cancer. Blood cancers comprise 10% of the oncology market.

It does have an ADC that was just approved for treatment of cervical cancer if standard chemotherapy fails.

[Guzzi62]

Thanks for a sane and down to earth post.

Yes, Genmab have a lot going on, well over 20 trials from pre-1-2&3, five in phase 3.

That was only one company, I wonder what the other BP are doing, waiting for DC-Vax?

Okay, I read somewhere that some of them have been cutting down on research and buys promising pre-revenue companies instead.

Hey BP, please buy NWBio now for 15 billion and I would be over the moon.